These findings suggest that miR-155 plays a critical role in downregulating CTLA4 mRNA in MCM-treated Treg cells but additional factors may be necessary for miR-155 to downregulate CTLA4 in Treg cells from melanoma. Here, CTLA4 is linked to melanoma.